Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03033602 · ClinicalTrials.gov registry record · NA
Brief Treatment for Posttraumatic Stress Disorder
A NA study, sponsored by Boston VA Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT03033602: Completed NA study, sponsored by Boston VA Research Institute.
NCT03033602 is a NA study that has completed, run by Boston VA Research Institute. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03033602, a NA study, has completed, sponsored by Boston VA Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.
Primary Outcome
The CAPS-5 is a semi-structured interview for assessment of PTSD according to DSM-5 diagnostic criteria. The measure assesses PTSD according to the 20 symptoms of DSM-5, as well as impairment. A total score is calculated as well as whether PTSD diagnosis is met. Scores can range from 0-80, with higher scores representing greater symptom severity. For this study, the CAPS-5 total score was used as the primary outcome measure.
Interventions
- BEHAVIORAL written exposure therapy
- BEHAVIORAL CPT, cognitive only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2015-07-20 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03033602 record still lists
NCT03033602 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which written exposure therapy is the first listed.
NCT03033602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03033602 about?
NCT03033602 is a clinical study titled "Brief Treatment for Posttraumatic Stress Disorder". The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.
What is the current status of trial NCT03033602?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2015-07-20. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03033602?
The interventions under investigation include: written exposure therapy (BEHAVIORAL), CPT, cognitive only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03033602?
This trial is sponsored by Boston VA Research Institute, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03033602's enrollment target sits among peer trials
169 619th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI